Navigation Links
Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
Date:11/6/2012

ainties, including those discussed in our most recent annual report filed on Form 10-K, in our quarterly reports filed on Form 10-Q, and in other reports filed by Array with the Securities and Exchange Commission. Because these statements reflect our current expectations concerning future events, our actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors. These factors include, but are not limited to, our ability to continue to fund and successfully progress internal research and development efforts and to create effective, commercially viable drugs; risks associated with our dependence on our collaborators for the clinical development and commercialization of our out-licensed drug candidates; the ability of our collaborators and of Array to meet objectives tied to milestones and royalties; our ability to effectively and timely conduct clinical trials in light of increasing costs and difficulties in locating appropriate trial sites and in enrolling patients who meet the criteria for certain clinical trials; risks associated with our dependence on third-party service providers to successfully conduct clinical trials within and outside the United States; our ability to achieve and maintain profitability and maintain sufficient cash resources; the extent to which the pharmaceutical and biotechnology industries are willing to in-license drug candidates for their product pipelines and to collaborate with and fund third parties on their drug discovery activities; our ability to out-license our proprietary candidates on favorable terms; and our ability to attract and retain experienced scientists and management. We are providing this information as of November 6, 2012. We undertake no duty to update any forward-looking statements to reflect the occurrence of events or circumstances after the date of such statements or of anticipated or unanticipated events that alter any assumptions underlying such stat
'/>"/>
SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
2. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
3. PDL BioPharma Announces Third Quarter 2012 Financial Results
4. PDL BioPharma to Announce Third Quarter 2012 Financial Results on November 5, 2012
5. New Study Highlights Enabling Factors for Biopharmaceutical Innovation in Middle-Income Countries
6. SAFC Enters South Korean BioPharma Market with CrystalGenomics Agreement
7. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
8. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
9. Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
10. PDL BioPharma Completes Regular Quarterly Dividend Payment
11. Chester County Biopharmaceutical Firm to Expand, Create 151 New Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... -- Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company ... B virus (HBV) infection, today announced the presentation of ... candidate, NVR 3-778, at the 2015 annual meeting of ... (EASL) in Vienna, Austria . ... performed in a humanized UPA/SCID mouse model was described ...
(Date:4/27/2015)... BRH Medical, Ltd., today announced ... Notification Application (510k) with the US Food and Drug ... Medical expects feedback from the FDA during the next ... following FDA pre-market clearance. Additional pre-market regulatory filings are ... CEO for BRH Medical, commented, "We are thrilled to ...
(Date:4/27/2015)... 27, 2015 Endo International plc (NASDAQ: ENDP ... results before the open of the U.S. financial markets on ... will host a conference call and webcast at 9:00 a.m. ... access the call is U.S./ Canada (866) ... Please dial in 10 minutes prior to the scheduled start ...
Breaking Medicine Technology:Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 2Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 3BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2
... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today that it ... , before the U.S. financial markets open. , ... Anadys will hold a conference call and webcast on Thursday, July ... its second quarter 2010 financial results and to provide an update on the ...
... SAN DIEGO , July 22 Neurocrine Biosciences, Inc. (Nasdaq: ... financial results after the Nasdaq market closes on Wednesday, July 28, 2010 ... its financial results and provide a Company update Thursday morning, July 29, ... Time ). , , , ...
Cached Medicine Technology:Anadys Pharmaceuticals to Report Second Quarter 2010 Financial Results 2Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results 2
(Date:4/27/2015)... According to a recent report from NIDCR (National ... pain, TMJ disorders are the second most prevalent ... addition, the report revealed that TMJ disorders affect about ... estimated 4 billion dollars annually. , These estimates suggest ... symptoms such as headaches, neck pain, tenderness of the ...
(Date:4/27/2015)... April 27, 2015 Beckman Coulter is ... sequencing to study the evolution of neural circuitry and ... will review the mechanisms by which analogous forms of ... body flexions, evolved independently in certain sea slug clades. ... broadcast live April 30, 2015 at 8:00am PT. , ...
(Date:4/27/2015)... 2015 As ISO 27001 has quickly ... companies of all sizes and in all industries, Pivot ... prepare for ISO 27001 certification. The information security audit ... them for ISO 27001 certification. Pivot Point's commitment to ... the number of Lead Implementers and Auditors the company ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Doctors on ... working on a lien basis for over twenty years. So ... find the best doctor in the Fresno area , ... Dilanchian, DC and his team of medical specialists. With ... a massage therapist, Dilanchian Chiropractic is now helping ...
(Date:4/27/2015)... Guided by the extensive work of its community ... collaboration with organizations around the world to identify proven ... essential actions for organizations committed to patient experience ... systems committed to providing the best in experience will:, ... with committed time and focused intent to shape and ...
Breaking Medicine News(10 mins):Health News:Dentist in Graham NC Reveals that a Jaw Disorder May Be the Cause of Chronic Headaches and Back Pain 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 3Health News:Six Additional New ISO 27001 Lead Implementers Certified for Pivot Point Security 2Health News:Eminent Doctor Joins Forces with Doctors on Liens in Fresno 2Health News:Guiding Principles for Patient Experience Excellence Identified by The Beryl Institute 2
... significant reduction in the teaching hours for medical subjects ... in a pathetic state where medical students are unable ... end up confusing one organ with another. In addition ... considerable reduction in the teaching hours for biochemistry, pathology, ...
... launched the Female Condom (FC) in India. It has partnered ... to market// their female condoms in India under the brand ... research before being able to launch the condom in India. ... first year. A pair of Confidom will cost Rs.250/-., ...
... among the teenagers in the recent years. But a new ... that they ever took such vows. // ,The ... good way of gauging how well they adhere to these ... form of public or written declarations to remain a virgin ...
... Mountain View, Calif.-based company is one of the leading ... Hence Long Island politician sued Google. He said that ... child pornography. Jeffrey Toback, a member of the Nassau ... contains pornography involving minors. In regard to this a ...
... used brain scans to try and study the biology of ... the brain pays to the expected pain // determines and ... suggesting that simple diversions could alleviate the misery. ... a new field called neuroeconomics that uses brain imaging to ...
... study undertaken by Ohio State University that chose to study the ... men have no compunctions opening up to others about their ... of the study Julianne Serovich says, “I was very surprised at ... HIV-positive men who deliberate very carefully on whether or not to ...
Cached Medicine News:Health News:Australian Medical Students Lack Anatomy Knowledge 2Health News:Teenagers Often Deny Taken ‘Virginity Pledges 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: